Wutah dodolan YoY sajrone 12 wulan kepungkur: Zymeworks Inc. (ZYME)

Logo perusahaan publik Zymeworks Biopharmaceuticals (ZYME)

The development of multi-specific antibodies and the success of zanidatamab establish a foundation for growth, as confirmed by the TTM revenue growth rate for Zymeworks Inc. (ZYME). Management's strategic focus on oncology and the launch of targeted therapies for solid tumors strengthen the financial base. Meanwhile, the 97.30 metric determines this level, capturing the final revenue dynamics relative to operating expenses.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Zymeworks (ZYME): kanggo periode 11.02.2024 - 16.11.2026

Zymeworks (ZYME) - rincian metrik lan laporan keuangan

- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Zymeworks Inc.
Sampel barang zymeworks.com

The development of cancer immunotherapy through strategic alliances with pharma behemoths directly impacts the rolling annual sales growth rate, reflecting the effectiveness of licensing agreements. The current value of 97.30 is calculated as the percentage deviation of TTM revenue from the same period last year, allowing investors to assess the business scaling pace and the fundamental resilience of Zymeworks Inc. (ZYME) amid industry cycles.

Pesaing Zymeworks Inc. (ZYME)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Tango Pharma (TNGX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur IOVA|IMTX - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur XNCR (Xencor Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CMPX|Wutah dodolan YoY (TTM) REPL (Replimune)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur LYEL|innate-pharma.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Pyxis Oncology|Compugen Limited (CGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|IO Biotech, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|STRO (sutrobio.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur